Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2011 Fourth Quarter and Year End Financial Results
Date:12/12/2011

els of those medications and/or NUEDEXTA. NUEDEXTA is contraindicated in patients receiving drugs that both prolong QT interval and are metabolized by CYP2D6 (e.g., thioridazine and pimozide) and should not be used concomitantly with other drugs containing quinidine, quinine, or mefloquine. NUEDEXTA is contraindicated in patients taking monoamine oxidase inhibitors (MAOIs) or in patients who have taken MAOIs within the preceding 14 days. NUEDEXTA is contraindicated in patients with a known hypersensitivity to its components.

NUEDEXTA may cause serious side effects, including possible changes in heart rhythm. NUEDEXTA is contraindicated in patients with a prolonged QT interval, congenital long QT syndrome or a history suggestive of torsades de pointes, in patients with heart failure as well as patients with, or at risk of, complete atrioventricular (AV) block, unless the patient has an implanted pacemaker.

NUEDEXTA causes dose-dependent QTc prolongation. When initiating NUEDEXTA in patients at risk of QT prolongation and torsades de pointes, electrocardiographic (ECG) evaluation of QT interval should be conducted at baseline and 3-4 hours after the first dose.

The most common adverse reactions in patients taking NUEDEXTA are diarrhea, dizziness, cough, vomiting, weakness, swelling of feet and ankles, urinary tract infection, flu, elevated liver enzymes, and flatulence.

NUEDEXTA may cause dizziness. Precautions to reduce the risk of falls should be taken, particularly for patients with motor impairment affecting gait or a history of falls.

Patients should take NUEDEXTA exactly as prescribed. Patients should not take more than 2 capsules in a 24-hour period, make sure that there is an approximate 12-hour interval between doses, and not take a double dose after they miss a dose.

These are not all the risks from use of NUEDEXTA. For additional important safety information about NUEDEXTA, please see the full Prescribing Informat
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine technology :

1. Avanir Pharmaceuticals Announces Date of Fiscal 2011 Fourth Quarter and Year End Financial Results and Conference Call
2. Avanir Pharmaceuticals to Participate in Piper Jaffray Health Care Conference
3. Avanir Pharmaceuticals Announces EMA Acceptance of Marketing Authorization Application for NUEDEXTA
4. Avanir Pharmaceuticals Submits European Marketing Authorization Application for NUEDEXTA
5. Avanir Pharmaceuticals to Present Data at the 2011 American Congress of Rehabilitation Medicine/American Society for Neurorehabilitation Medicine Annual Conference
6. Avanir Pharmaceuticals to Participate in Two Investor Conferences
7. Avanir Pharmaceuticals to Present at Stifel Nicolaus Healthcare Conference
8. Avanir Pharmaceuticals Files Lawsuits Against Par and Actavis for Infringement of NUEDEXTA Patents
9. Avanir Pharmaceuticals Reports Fiscal 2011 Third Quarter Financial Results
10. Avanir Pharmaceuticals Announces Appointment of Dr. Joao Siffert as Senior Vice President Research and Development
11. Avanir Pharmaceuticals to Present at Two Investor Conferences in August
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... (NADDI) today lauded the latest results achieved by ... system, known as the National Precursor Log Exchange ... law enforcement officials track down meth offenders and ... technology in Kansas blocked ...
(Date:8/20/2014)... Reportlinker.com announces that a new market ... The Impact of Healthcare Reform (PPACA) On ... http://www.reportlinker.com/p01618927/The-Impact-of-Healthcare-Reform-PPACA-On-the-US-IVD-Industry.html The "Patient Protection and ... that affects virtually every aspect of health care, ... take effect now. IVD manufacturers who have different ...
(Date:8/20/2014)... DUBLIN , Aug. 20, 2014 ... addition of the "Global Biosimilars/Follow-on-Biologics Market (Technology, ... 2013 - 2020" report to their offering. ... biosimilars/follow-on-biologics market (types, applications and geography) - Size, ... Research, Report, Opportunities, Segmentation and Forecast, 2013 - ...
Breaking Medicine Technology:Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 2The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 3The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 4The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 5The Impact of Healthcare Reform (PPACA) On the U.S. IVD Industry 6Global Biosimilars/Follow-on-Biologics Market (Technology, Types, Applications, Services and Geography) - Research Report, 2013 - 2020 2
... CITY , April 28 Sonic Innovations, Inc. (Sonic), the ... conducting ongoing training events for government clinicians.  The company has just completed ... San Diego, California and April 25 through 27 in ... 3 through 5 in Salt Lake City, Utah , ...
... April 28 The Wireless-Life Sciences Alliance ... its Wireless Health Commercialization Day on May 13, 2010 ... Convergence Summit, a three-day conference sponsored by the premier trade ... wireless communications technologies. The conference is scheduled for May ...
Cached Medicine Technology:Sonic Innovations Conducts National Training Events for Government Clinicians 2Sonic Innovations Conducts National Training Events for Government Clinicians 3Thought Leaders Shaping the Emerging Wireless Life Science Space to Share Vision and Insights at WLSA Convergence Summit 2Thought Leaders Shaping the Emerging Wireless Life Science Space to Share Vision and Insights at WLSA Convergence Summit 3Thought Leaders Shaping the Emerging Wireless Life Science Space to Share Vision and Insights at WLSA Convergence Summit 4
(Date:8/21/2014)... AttorneyOne.com, a recognized authority on law, ... from the FDA on Dianeal Low Calcium (2.5mEq/L) ... on August 15, that two lots of Dianeal Low ... (Ambu-Flex II), by Baxter International Inc., are recalled ... , The reason for the recall is the presence ...
(Date:8/21/2014)... The employees of Pharmica Consulting ... Pennsylvania on Thursday, August 7th to spend their day ... for different ways that Pharmica could get involved with ... Consulting. “When we heard that we could help preserve ... at the opportunity.” , Pharmica spent their day tackling ...
(Date:8/21/2014)... She was 12 years old when the unthinkable ... surgery to correct her frequent headaches failed. , In ... Strom-Stewart shares her journey of overcoming devastating obstacles involving dual ... miscarriage of justice for years. , “My faith in ... into the light,” Strom-Stewart said. “But it took me more ...
(Date:8/21/2014)... The rising numbers of teen drug and alcohol abuse ... years, countless lives have been lost due to teenager addiction. ... helpline was established to provide a valuable source of information ... overcome their youth substance abuse issues. , ... 257-4053, parents and their teens can speak immediately to a ...
(Date:8/21/2014)... 21, 2014 Michael E. Steuer , ... roots back to the Bluff City with recent philanthropy at ... those in the United States,” says friend and Rabbi David ... outreach programs, such as providing in-house for the needy and ... by serving in the local synagogue. And to remain close ...
Breaking Medicine News(10 mins):Health News:Dianeal Low Calcium (2.5mEq/L) Peritoneal Dialysis Solution with 2.5% Dextrose 5000mL (Ambu-Flex II) Recalled: AttorneyOne Monitors and Keeps Consumers Informed 2Health News:Pharmica Spends the Day Helping to Preserve Washington Crossing Historic Park 2Health News:The Dramatic, Uplifting Story from a Brain Injured Woman 2Health News:Troubled Teens in Boynton Beach, FL Turn to Helpline for Valuable Assistance 2
... Income in Company History, BELLEVUE, Wash., Feb. 6 ... provider of health, beauty, vision, and,pharmacy products, today announced ... ended December 30, 2007. The company reported,quarterly net sales ... $0.00,per share. The company achieved record gross margins in ...
... of Mobility Program Helps Eden Home Resident regain mobility and,Be ... is a "sweetheart with a sweet tooth" say his friends ... a borrowed power wheelchair,from delivering mail at the facility where ... self-professed "chocoholic." To keep him on the,go, The SCOOTER Store ...
... 6 The Juvenile,Products Manufacturers Association (JPMA), which ... United States, stands by the,scientific research indicating that ... to fall victim to scare tactics., There ... Bisphenol-A, a,material used to make tough, shatter-resistant polycarbonate ...
... Va., Feb. 6 The HealthCentral,Network, Inc. ... accomplished dermatologist, cosmetic surgeon and author, is,joining the ... Sundaram is the author of Face Value: The ... It [Rodale], which was honored by,the National Press ...
... Medical,Innovations, Inc. (Amex: IMA ), a leading ... consumer and professional markets, announced,today that it will ... being held February 11 through 13, 2008 at ... Zwanziger, Chief Executive Officer, and Jon Russell,Vice President, ...
... saves lives. It saves money. And it,s time., ... of the,growing momentum for electronic prescribing (e-prescribing), Health ... before the,Senate Finance Committee that e-prescribing standards and ... adopt the technology in Medicare., When questioned ...
Cached Medicine News:Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 2Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 3Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 4Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 5Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 6Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 7Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 8Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 9Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 10Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 11Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 12Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 13Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 14Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 15Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 16Health News:drugstore.com inc. Achieves GAAP Profitability in the Fourth Quarter of 2007 17Health News:The SCOOTER Store Donates Power Wheelchair to New Braunfels Car Crash Victim 2Health News:JPMA on the Safety of Baby Bottles 2Health News:Prominent Cosmetic Dermatologist and Author Joins MySkinCareConnection.com 2Health News:Prominent Cosmetic Dermatologist and Author Joins MySkinCareConnection.com 3Health News:Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008 2Health News:PCMA Applauds Secretary Leavitt's Support for Requiring E-Prescribing in Medicare 2Health News:PCMA Applauds Secretary Leavitt's Support for Requiring E-Prescribing in Medicare 3
... was designed with thinner, long jaws ... IOL through a tunnel or clear ... the lens securely, but will not ... wide enough to allow the lens ...
Titanium. Curved 18 mm shafts with 1.5 wide grasping tip. Flat, serrated cross action handle with dull finish....
45 degree. Angled shafts. Tip to angle length: 11.5 mm. Stops in handle designed to prevent "over folding". Manufactured in titanium....
Excellent for inserting rigid or flexible implants. Rounded tips provide excellent purchase of the optic...
Medicine Products: